Cargando…

Recent insights in the role of biomarkers in severe asthma management

Contemporary asthma management requires a proactive and individualized approach, combining precision diagnosis and personalized treatment. The introduction of biologic therapies for severe asthma to everyday clinical practice, increases the need for specific patient selection, prediction of outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fouka, Evangelia, Domvri, Kalliopi, Gkakou, Foteini, Alevizaki, Maria, Steiropoulos, Paschalis, Papakosta, Despoina, Porpodis, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548530/ https://www.ncbi.nlm.nih.gov/pubmed/36226150 http://dx.doi.org/10.3389/fmed.2022.992565

Ejemplares similares

Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice
por: Porpodis, Konstantinos, et al.
Publicado: (2022)

Cytokine gene polymorphisms in Greek patients with severe asthma
por: Papakosta, Despina, et al.
Publicado: (2015)

Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions
por: Fouka, Evangelia, et al.
Publicado: (2022)

Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression
por: Domvri, Kalliopi, et al.
Publicado: (2023)

Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
por: Kotoulas, Serafeim Chrysovalantis, et al.
Publicado: (2022)

Clinical, imaging and functional determinants of sarcoidosis phenotypes in a Greek population
por: Spyropoulos, Georgios, et al.
Publicado: (2022)

Electronic Cigarettes and Asthma: What Do We Know So Far?
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2021)

Epidemiology of lung cancer in Northern Greece: An 18-year hospital-based cohort study focused on the differences between smokers and non-smokers
por: Domvri, Kalliopi, et al.
Publicado: (2020)

Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2023)

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Health costs from hospitalization with H1N1 infection during the 2009–2010 influenza pandemic compared with non-H1N1 respiratory infections
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

COVID-19 Advanced Care
por: Fouka, Evangelia, et al.
Publicado: (2021)

Biologic Therapies in Pediatric Asthma
por: Perikleous, Evanthia P., et al.
Publicado: (2022)

Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
por: Archontogeorgis, Konstantinos, et al.
Publicado: (2014)

Vitamin D in asthma and future perspectives
por: Huang, Haidong, et al.
Publicado: (2013)

BALF and BLOOD NK- cells in different stages of pulmonary sarcoidosis
por: Manika, Katerina, et al.
Publicado: (2021)

Immunotherapy and Chemotherapy Versus Sleep Disturbances for NSCLC Patients
por: Zarogoulidis, Paul, et al.
Publicado: (2023)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Association of Asthma and Allergic Rhinitis With Sleep-Disordered Breathing in Childhood
por: Perikleous, Evanthia, et al.
Publicado: (2018)

Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer
por: Domvri, Kalliopi, et al.
Publicado: (2017)

Changes in Exercise Capacity of Patients With Obstructive Sleep Apnea Following Treatment With Continuous Positive Airway Pressure
por: Pigakis, Konstantinos M, et al.
Publicado: (2022)

Inhaled chemotherapy in lung cancer: future concept of nanomedicine
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
por: Domvri, Kalliopi, et al.
Publicado: (2013)

Zarogouldis, P., et al., Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology. Int. J. Mol. Sci. 2012, 13, 10828–10862
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology
por: Zarogouldis, Paul, et al.
Publicado: (2012)

Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival
por: Zarogoulidis, Paul, et al.
Publicado: (2023)

New developments in the management of COPD: clinical utility of indacaterol 75 μg
por: Steiropoulos, Paschalis, et al.
Publicado: (2013)

Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2021)

Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation
por: Domvri, Kalliopi, et al.
Publicado: (2020)

Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2023)

Effect of the Implementation of a Structured Diet Management Plan on the Severity of Obstructive Sleep Apnea: A Systematic Review
por: Rokou, Aikaterini, et al.
Publicado: (2022)

Challenges in severe asthma: Do we need new drugs or new biomarkers?
por: Adatia, Adil, et al.
Publicado: (2022)

Coexistent obstructive sleep apnea in patients with chronic obstructive pulmonary disease: Several unanswered questions need to be addressed
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

Recent Insights into the Management of Inflammation in Asthma
por: Rupani, Hitasha, et al.
Publicado: (2021)

Vitamin D Levels in Patients with Overlap Syndrome, Is It Associated with Disease Severity?
por: Archontogeorgis, Kostas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n8c4663am2h1o8rvlb8ecadep